Cargando…
Tuberculosis and pharmacological interactions: A narrative review
Even if major improvements in therapeutic regimens and treatment outcomes have been progressively achieved, tuberculosis (TB) remains the leading cause of death from a single infectious microorganism. To improve TB treatment success as well as patients' quality of life, drug-drug-interactions (...
Autores principales: | Riccardi, Niccolò, Canetti, Diana, Rodari, Paola, Besozzi, Giorgio, Saderi, Laura, Dettori, Marco, Codecasa, Luigi R., Sotgiu, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663953/ https://www.ncbi.nlm.nih.gov/pubmed/34909643 http://dx.doi.org/10.1016/j.crphar.2020.100007 |
Ejemplares similares
-
Pharmacological interactions: Synergism, or not synergism, that is the question
por: Calzetta, Luigino, et al.
Publicado: (2021) -
The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions
por: Wang, Jingya, et al.
Publicado: (2021) -
Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases
por: Bellia, Alfonso, et al.
Publicado: (2021) -
Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
por: Geng, Yong-Jian, et al.
Publicado: (2021) -
From dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure
por: Garoffolo, Gloria, et al.
Publicado: (2021)